Chronological Analysis of First-in-Class Drugs Approved from 2011 to 2022: Their Technological Trend and Origin
The discovery and development of first-in-class (FIC) drugs are becoming increasingly important due to increasing reimbursement pressure and personalized medication. To investigate the technological trends and origin of FIC drugs, the FIC drugs approved in the U.S. from January 2011 to December 2022...
Main Author: | Ryo Okuyama |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/7/1794 |
Similar Items
-
Modality diversification and best-in-class small-molecule drugs: Recent trend of orphan drug development
by: Ryo Okuyama
Published: (2023-06-01) -
The Relationship between Family-Owned Business and the Success of Small Medium Enterprise
by: Rian Adriansah, et al.
Published: (2023-08-01) -
Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022
by: Mingxiao Gu, et al.
Published: (2023-12-01) -
How small and medium-sized family enterprises in the tourism sector develop inter-organisational relationships: a case study
by: Hanna Łobejko
Published: (2022-07-01) -
PERANAN TENAGA KERJA PEREMPUAN PADA UKM DEPOK DALAM MENINGKATKAN PENDAPATAN RUMAH TANGGA
by: M. B. Nani Ariani, et al.
Published: (2016-12-01)